REDUCTION IN EXHALED NITRIC OXIDE (FENO) WITH DUPILUMAB AFTER PRIOR RESISTANCE TO ANTI-TH-2 BIOLOGICALS

被引：0
|
作者：
Cohen, B.
Eisenberg, R.
Rubinstein, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.192
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M205
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 44 条
  • [1] Reduction of fractional exhaled nitric oxide (FENO) and its variation by mouth wash
    Piirila, Paivi
    Rouhos, Annamari
    Kainu, Annette
    Sovijarvi, Anssi R. A.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (03): : 253 - 257
  • [2] BASELINE EXHALED NITRIC OXIDE (FENO) AS PREDICTOR OF RESPONSE TO DUPILUMAB IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA
    Pavord, I.
    Busse, W.
    Corren, J.
    Casale, T.
    FitzGerald, M.
    Daizadeh, N.
    Ortiz, B.
    Johnson, R.
    Harel, S.
    Rowe, P.
    Deniz, Y.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S34 - S34
  • [3] Efficacy of Dupilumab in Patients With and Without a Minimally Important Reduction in Fractional Exhaled Nitric Oxide After 2 Weeks of Treatment
    Pavord, I. D.
    Wechsler, M. E.
    Busse, W.
    Domingo Ribas, C.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Jacob-Nara, J. A.
    Radwan, A.
    Rowe, P. J.
    Deniz, Y. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA WITH/WITHOUT SUBSTANTIAL REDUCTION IN FRACTIONAL EXHALED NITRIC OXIDE
    Halpin, D.
    Korn, S.
    Matucci, A.
    Bourdin, A.
    Daizadeh, N.
    Ortiz, B.
    Djandji, M.
    Deniz, Y.
    Rowe, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S34 - S34
  • [5] Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab
    Pavord, I. D.
    Deniz, Y.
    Casale, T.
    Corren, J.
    Fitzgerald, M.
    Daizadeh, N.
    Jagerschmidt, A.
    Dillon, M.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Busse, W. W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Efficacy of dupilumab in patients with asthma stratified by a minimally important fractional exhaled nitric oxide reduction at week 2 of treatment
    Pavord, I.
    Wechsler, M.
    Busse, W. W.
    Domingo, C.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Jacob-Nara, J. A.
    Amr, R.
    Rowe, P. J.
    Deniz, Y.
    ALLERGY, 2023, 78 : 183 - 183
  • [7] Ethnic Differences in Exhaled Nitric Oxide (FeNO) Before, During, and After an Asthma Exacerbation in Children with Asthma
    McCormack, Katherine
    Malka, Jonathan
    Gleason, Melanie C.
    Spahn, Joseph D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB196 - AB196
  • [8] Reduction in exhaled nitric oxide immediately after methacholine challenge in asthmatic children
    Piacentini, GL
    Bodini, A
    Peroni, DG
    Del Giudice, MM
    Costella, S
    Boner, AL
    THORAX, 2002, 57 (09) : 771 - 773
  • [9] The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
    Tsyplenkova, Svetlana
    Mizernitskyi, Yuriy
    Sokolova, Ludmila
    Sorokina, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Exhaled Nitric Oxide (FeNO) and T-Helper 2 Cell Biomarkers: Can They Predict Treatment Response To Dupilumab, An IL-4Rα Antibody, In An Eosinophilic Asthma Population?
    Swanson, Brian N.
    Wang, Lin
    Ming, Jeffrey
    Hamilton, Jennifer D.
    Teper, Ariel
    Dicioccio, Thomas
    Li, Yongtao
    Graham, Neil
    Pirozzi, Gianluca
    Wenzel, Sally E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB85 - AB85
12345